Vestibular and oculomotor abnormalities among HIV-infected and HIV-uninfected men and women: A pilot study.


Journal

Journal of vestibular research : equilibrium & orientation
ISSN: 1878-6464
Titre abrégé: J Vestib Res
Pays: Netherlands
ID NLM: 9104163

Informations de publication

Date de publication:
2020
Historique:
pubmed: 4 8 2020
medline: 9 10 2021
entrez: 4 8 2020
Statut: ppublish

Résumé

To determine if middle-aged and aging men and women with HIV disease (HIV+) should be screened for vestibular and oculomotor dysfunction. Age- and sociodemographically matched HIV+ and HIV- men and women were tested on vestibular evoked myogenic potential (VEMP), bi-thermic caloric testing, Dix-Hallpike maneuvers and saccades. HIV+ men had more caloric weakness than HIV- men. HIV+ subjects had more saccade abnormalities than HIV- subjects. A saccade abnormality was positively associated with being HIV+. Among the HIV+ sample, abnormalities were associated with increasing age, being male, ever taking monotherapy, and having an undetectable viral load. Only being male and having an undetectable viral load were statistically significant. Unilateral caloric weakness had a decreased prevalence with age per 10 years, and being HIV+ showed an increased prevalence. In HIV+ subjects only, these abnormalities decreased with age and being male but increased with undetectable viral load and ever taking antiretroviral monotherapy. No statistically significant differences were found. Women are at greater risk of vestibular and oculomotor abnormalities than men. HIV+ adults are at greater risk than HIV- adults. Physicians who care for HIV+ men and women should monitor the symptoms of vestibular and oculomotor impairment.

Identifiants

pubmed: 32741798
pii: VES200707
doi: 10.3233/VES-200707
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-334

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC009031
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146193
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146205
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000004
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI050409
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI050410
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027767
Pays : United States

Auteurs

Matthew D Pichert (MD)

Georgetown University School of Medicine, Washington, DC, USA.

Michael W Plankey (MW)

Georgetown University Medical Center, Washington, DC, USA.

Gayle Springer (G)

Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

Christopher Cox (C)

Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

Howard J Hoffman (HJ)

National Institute on Deafness and Other Communication Disorders, National Instiutes of Health, Bethesda, MD, USA.

Helen S Cohen (HS)

Baylor College of Medicine, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH